Is low dose of Estrogen beneficial for prevention of glaucoma?

Medical Hypotheses

Volumn 79, Issue 3, 2012, Pages 377-380

  Wei, Xin ^a   Cai, Su Ping ^a   Zhang, Xiulan ^b   Li, Xiaohong ^a   Chen, Xiaoming ^a   Liu, Xuyang ^a  

^a SICHUAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN FIBER; ELASTIN; ESTROGEN; ESTROGEN RECEPTOR;

ARTICLE; CELL MOTION; CELL SURVIVAL; CORNEA; CRIBRIFORM FORAMINA; ELASTICITY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LAMINA CRIBROSA; LOW DRUG DOSE; MENOPAUSE; NERVE FIBER; NONHUMAN; PROTEIN EXPRESSION; RETINA GANGLION CELL; SCLERA; TISSUES;

COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; GLAUCOMA; HUMANS; RECEPTORS, ESTROGEN;

EID: 84864597047     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.05.041     Document Type: Article

References (38)

1. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006, 90:262-267.
2. Quigley H.A. Open-angle glaucoma. N Engl J Med 1993, 328:1097-1106.
3. Foster P.J. The epidemiology of primary angle closure and associated glaucomatous optic neuropathy. Semin Ophthalmol 2002, 17:50-58.
4. Goldblum D., Mittag T. Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye. Vision Res 2002, 42:471-478.
5. Anderson D.R., Drance S.M., Schulzer M. Collaborative Normal-Tension Glaucoma Study Group. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol 2003, 136:820-829.
6. Yoshikawa K., Inoue Y. Changes in optic disc parameters after intraocular pressure reduction in adult glaucoma patients. Jpn J Ophthalmol 1999, 43:225-231.
7. Zhang Shisheng., Wang Kangsun The progress between eye and estrogen. Rec Adv Ophthalmol 2001, 21(2):133-135.
8. Russo R., Cavaliere F., Watanabe C., Nucci C., Begatta G., Corasaniti M.T., et al. 17β-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res 2008, 173:583-590.
9. Sorrentino C., Affinito P., Mattace R.F., et al. Effect of hormone replacement therapy on postmenopausal ocular function. Minerva Ginecol 1998, 50:19-24.
10. Guttridge N.M. Changes in ocular and visual variables during the menstrual cycle. Ophthalmic Physiol Opt 1994 Jan, 14(1):38-48.
11. Hulsman C.A., Westendorp I.C., Ramrattan R.S., Wolfs R.C., Witteman J.C., Vingerling J.R., et al. Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol 2001, 154(2):138-144.
12. Spoerl Eberhard., Boehm Andreas.G., Pillunat Lutz.E. The influence of various substances on the biomechanical behavior of lamina cribrosa and peripapillary sclera. Invest Ophthalmol Vis Sci 2005, 46:1286-1290.
13. Quigley H.A., Addicks E.M. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol 1981, 99:137-142.
14. Pena J. Elastosis of the lamina cribrosa in glaucomatous optic neuropathy. Exp Eye Res 1998, 67:517-524.
15. Sommer A. Intraocular pressure and glaucoma. Am Ophthalmol. 1989, 107:186-188.
16. Quigley H.A., Dorman-Pease M.E., Brown A.E. Quantitative study of collagen and elastin of the optic nerve head and sclera in human and experimental glaucoma. Curr Eye Res 1991, 10:877-888.
17. Albon Julie., Karwatowski Wojciech S.S. Changes in the collagenous matrix of the aging human lamina cribrosa. Br J Ophthalmol 1995, 79:368-375.
18. Jonas J., Mardin C., Schlotzer-Schrehardt U., Naumann G. Morphometry of the human lamina cribrosa surface. Invest Ophthalmol Vis Sci 1991, 32:401-405.
19. Morgan-Davies J., Taylor N., Hill A.R., Aspinall P., O'Brien C.J., Azuara-Blanco A. Three dimensional analysis of the lamina cribrosa in glaucoma. Br J Ophthalmol 2004, 88(10):1299-1304.
20. Yan D., Coloma F., Metheetrairut A., Trope G., Heathcote J., Ethier C. Deformation of the lamina cribrosa by elevated intraocular pressure. BMJ 1994, 643-648.
21. Dahlman-Wright K., Cavailles V., Fuqua S.A., Jordan V.C., Katzenellenbogen J.A., Korach K.S., et al. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 2006, 58(4):773-781.
22. Wickham L.A., Jianping Gao, Ikuko Toda, Rocha Eduardo M, Masafumi Ono, Sullivan David A Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000, 78(2):146-153.
23. Kobayashi K., Kobayashi H., Ueda M., Honda Y. Estrogen receptor expression in bovine and rat retinas. Invest Ophthalmol Vis Sci 1998, 39(11):2105-2110.
24. Giuffrè G., Di Rosa L., Fiorino F., Bubella D.M., Lodato G. Variations in central corneal thickness during the menstrual cycle in women. Cornea 2007, 26(2):144-146.
25. Spoerl E., Zubaty V., Raiskup-Wolf F., Pillunat L.E. Oestrogen-induced changes in biomechanics in the cornea as a possible reason for keratectasia. Br J Ophthalmol 2007, 91(11):1547-1550.
26. Leach N.E., Wallis N.E., Lothringer L.L., et al. Corneal hydration changes during the normal menstrual cycle: a preliminary study. J Reprod Med 1971, 6:201-204.
27. Kiely P.M., Carney L.G., Smith G. Menstrual cycle variations of corneal topography and thickness. Am J Physiol Opt 1983, 60:822-829.
28. Altintas O., Caglar Y., Yuksel N., Demirci A., Karabas L. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 2004, 218:120-129.
29. Affinito P., Di Spiezio Sardo A., et al. Effects of hormone replacement therapy on ocular function in postmenopause. Menopause 2003, 10:482-487.
30. Taner P., Akarsu C., Atasoy P., Bayram M., Ergin A. The effects of hormone replacement therapy on ocular surface and tear function test in postmenopausal women. Ophthalmologica 2004, 218:257-259.
31. Russo R., Cavaliere F., Watanabe C., et al. 17Beta-estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res 2008, 173:583-590.
32. Zhou X., Li F., Ge J., Sarkisian S.R., et al. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma. Dev Neurobiol 2007, 67(5):603-616.
33. Resnikoff S., Pascolini D., Etya'ale D., et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004, 82:844-851.
34. Bellezza A.J., Rintalan C.J., Thompson H.W., Downs J.C., Hart R.T., Burgoyne C.F. Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma. Invest Ophthalmol Vis Sci 2003, 44:623-637.
35. Komatsuda T., Sugita T., Sano H., et al. Does estrogen alter the mechanical properties of the anterior cruciate ligament? An experimental study in rabbits. Acta Ortho 2006, 77:973-980.
36. Pasquale L.R., Kang J.H. Female reproductive factors and primary open-angle glaucoma in the Nurses' Health Study. Eye 2011, 25:633-641.
37. Vajaranant T.S., Nayak S., Wilensky J.T., et al. Gender and glaucoma: what we know and what we need to know. Curr Opin Ophthalmol 2010, 21(2):91-99.
38. Mabuchia Fumihiko., Sakuradaa Yoichi., Kashiwagia Kenji., et al. Estrogen receptor beta gene polymorphism and intraocular pressure elevation in female patients with primary open-angle glaucoma. A J Ophthalmol 2010, 149(5):826-830.